Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Dendreon (DNDN +1.1%) sells its immunotherapy manufacturing facility in Morris Plains, New...

  • Thursday, December 20, 2012, 10:09 AM ET
    Dendreon (DNDN +1.1%) sells its immunotherapy manufacturing facility in Morris Plains, New Jersey, to Novartis (NVS) for $43M in cash. The sale is part of Dendreon's restructuring plans on "its path to profitability and future growth." The plant was used to manufacture cancer drug Provenge, which has had its marketing troubles.
Track new comments on this story

This news story has 1 comment:

  •  
    Lower expenses, plus cash - a step in the right direction.
    20 Dec 2012, 10:13 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »